miR-31 in duchenne muscular dystrophy therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9034838
APP PUB NO 20120129920A1
SERIAL NO

13322023

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the therapy of Duchenne Muscular Dystrophy (DMD) by means of modulating the amount of a specific miRNA (miR-31).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITA DEGLI STUDI DI ROMA "LA SAPIENZA"PIAZZALE ALDO MORO 5 ROME 00185

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bozzoni, Irene Rome, IT 7 87
Cacchiarelli, Davide Rome, IT 3 43
Incitti, Tania Rome, IT 2 41
Martone, Julie Rome, IT 2 39

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 19, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00